Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 256 publications
In Vivo Base Editing of PCSK9 with VERVE-102 for Hypercholesterolemia.
Journal: The New England journal of medicine
Published: May 26, 2026
Pharmacotherapy of cardiovascular diseases from herbs and pills to nucleic acids.
Journal: European heart journal
Published: November 27, 2024
New Approaches for Targeting PCSK9: Small-Interfering Ribonucleic Acid and Genome Editing.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: June 01, 2023
Author Correction: The power of genetic diversity in genome-wide association studies of lipids.
Journal: Nature
Published: May 26, 2023
Spacer Fidelity Assessments of Guide RNA by Top-Down Mass Spectrometry.
Journal: ACS central science
Published: March 08, 2023
Efficacy and Safety of an Investigational Single-Course CRISPR Base-Editing Therapy Targeting PCSK9 in Nonhuman Primate and Mouse Models.
Journal: Circulation
Published: October 31, 2022
Gene Sequencing Identifies Perturbation in Nitric Oxide Signaling as a Nonlipid Molecular Subtype of Coronary Artery Disease.
Journal: Circulation. Genomic and precision medicine
Published: October 10, 2022
Association of Habitual Alcohol Intake With Risk of Cardiovascular Disease.
Journal: JAMA network open
Published: March 25, 2022
GalNAc-Lipid nanoparticles enable non-LDLR dependent hepatic delivery of a CRISPR base editing therapy.
Journal: Nature communications
Published: March 03, 2022
A multi-layer functional genomic analysis to understand noncoding genetic variation in lipids.
Journal: American journal of human genetics
Published: December 02, 2021
Author Correction: A high-resolution HLA reference panel capturing global population diversity enables multi-ancestry fine-mapping in HIV host response.
Journal: Nature genetics
Published: November 03, 2021
Last Updated: 09/26/2026